84
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients

ORCID Icon, , &
Pages 10827-10839 | Published online: 30 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jiaxin Cao, Fan Luo, Kangmei Zeng, Wenjuan Ma, Feiteng Lu, Yan Huang, Li Zhang & Hongyun Zhao. (2022) Predictive Value of High Preoperative Serum Total Protein and Elevated Hematocrit in Patients with Non-Small-Cell Lung Cancer after Radical Resection. Nutrition and Cancer 74:10, pages 3533-3545.
Read now
Jie-Yu Zhou, Kang-Kang Lu, Wei-Da Fu, Hao Shi, Jun-Wei Gu, Yi-Qiao Lu & Gui-Long Guo. (2021) Development of prognostic nomograms using institutional data for patients with triple-negative breast cancer. Future Oncology 17:36, pages 5077-5091.
Read now
Shuai Yan, Wenjie Wang, Bifa Zhu, Xixi Pan, Xiaoyan Wu & Weiyang Tao. (2020) Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer. Cancer Management and Research 12, pages 8313-8323.
Read now

Articles from other publishers (11)

Junjie Niu, Jinyang Hu & Zhu Wang. (2024) Scutellaria barbata D.Don extract regulates Ezrin-mediated triple negative breast cancer progress via suppressing the RhoA /ROCK1 signaling. Toxicology Research 13:2.
Crossref
Shuang-Long Cai, Jing-Jing Liu, Ying-Xue Liu, Shao-Hong Yu, Xu Liu, Xiu-Quan Lin, Hong-Dan Chen, Xuan Fang, Tao Ma, Ya-Qing Li, Ying Li, Chun-Yan Li, Sheng Zhang, Xiao-Geng Chen, Xiao-Jing Guo & Jin Zhang. (2023) Characteristics of recurrence, predictors for relapse and prognosis of rapid relapse triple-negative breast cancer. Frontiers in Oncology 13.
Crossref
Ruiyang Wu, Jing Luo, Hangyu Wan, Haiyan Zhang, Yewei Yuan, Huihua Hu, Jinyan Feng, Jing Wen, Yan Wang, Junyan Li, Qi Liang, Fengjiao Gan & Gang Zhang. (2023) Evaluation of machine learning algorithms for the prognosis of breast cancer from the Surveillance, Epidemiology, and End Results database. PLOS ONE 18:1, pages e0280340.
Crossref
Wei-Xun Lin, Yan-Na Xie, Yao-Kun Chen, Jie-Hui Cai, Juan Zou, Jie-Hua Zheng, Yi-Yuan Liu, Zhi-Yang Li & Ye-Xi Chen. (2022) Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery. World Journal of Clinical Cases 10:31, pages 11338-11348.
Crossref
Lei Zhang, Xudong Zhang, Peng Han, Dantong Zhao, Nana Hu, Wei Fan, Panting Wang, Xiaoxuan Zuo, Hanqing Kong, Fuhui Peng, Jiawei Tian & Hao Cui. (2022) Nomograms predicting recurrence in patients with triple negative breast cancer based on ultrasound and clinicopathological features. The British Journal of Radiology 95:1138.
Crossref
Guoliang Qiao, Crisanta H. Ilagan, Carlos Fernandez-del Castillo, Cristina R. Ferrone, Quisette P. Janseen, Vinod P. Balachandran, Naomi M. Sell, Jeffrey A. Drebin, Thomas Hank, T. Peter Kingham, Michael I. D’Angelica, William R. Jarnagin, Keith D. Lillemoe, Alice C. Wei & Motaz Qadan. (2022) Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy. Surgery 172:4, pages 1228-1235.
Crossref
Hang Chen, Yu Min, Ke Xiang, Jialin Chen & Guobing Yin. (2022) DCE-MRI Performance in Triple Negative Breast Cancers: Comparison with Non-Triple Negative Breast Cancers. Current Medical Imaging Formerly Current Medical Imaging Reviews 18:9, pages 970-976.
Crossref
Fangfang Duan, Jianpei Li, Jiajia Huang, Xin Hua, Chenge Song, Li Wang, Xiwen Bi, Wen Xia & Zhongyu Yuan. (2021) Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Xin Hua, Fangfang Duan, Jiajia Huang, Xiwen Bi, Wen Xia, Chenge Song, Li Wang, Chang Jiang & Zhongyu Yuan. (2021) A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Rana Aldrees, Xiaoqing Gao, Kui Zhang, Gene P. Siegal & Shi Wei. (2021) Validation of the revised 8th AJCC breast cancer clinical prognostic staging system: analysis of 5321 cases from a single institution. Modern Pathology 34:2, pages 291-299.
Crossref
Liwei Wu, Wei Chang, Yanzheng Song & Lin Wang. (2020) Predicting treatment failure risk in a Chinese Drug-Resistant Tuberculosis with surgical therapy: Development and assessment of a new predictive nomogram. International Journal of Infectious Diseases 96, pages 88-93.
Crossref